{ "cik": 1377121, "cik_padded": "0001377121", "entityName": "Protagonist Therapeutics, Inc", "fiscal_years": [ { "accn": "0001104659-26-019696", "filed": "2026-02-25", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1590000.0, "cash": 128390000.0, "eps_diluted": -2.05, "free_cash_flow": 56081000.0, "net_income": -130149000.0, "operating_cash_flow": 57671000.0, "operating_income": -158127000.0, "revenue": 46016000.0, "stockholders_equity": 614707000.0, "total_assets": 668188000.0, "total_liabilities": 53481000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.08700242554582915, "revenue_growth_yoy": -0.8940780281424293, "roa_avg2y": -0.18422790362888586, "roa_period_end": -0.19477901428939162, "roe_avg2y": -0.2017810825099496, "roe_period_end": -0.2117252609779944 } }, { "accn": "0001104659-26-019696", "filed": "2026-02-25", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1355000.0, "cash": 97249000.0, "eps_diluted": 4.23, "free_cash_flow": 182797000.0, "net_income": 275188000.0, "operating_cash_flow": 184152000.0, "operating_income": 252843000.0, "revenue": 434433000.0, "stockholders_equity": 675295000.0, "total_assets": 744725000.0, "total_liabilities": 69430000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.102814325591038, "net_margin": 0.6334417505115864, "operating_margin": 0.5820068917416494, "revenue_growth_yoy": 6.24055, "roa_avg2y": 0.4991275769128919, "roa_period_end": 0.3695162643928967, "roe_avg2y": 0.5438648500156131, "roe_period_end": 0.4075078299113721 } }, { "accn": "0001558370-25-001317", "filed": "2026-02-25", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 609000.0, "cash": 186727000.0, "eps_diluted": -1.39, "free_cash_flow": -70845000.0, "net_income": -78955000.0, "operating_cash_flow": -70236000.0, "operating_income": -93652000.0, "revenue": 60000000.0, "stockholders_equity": 336677000.0, "total_assets": 357951000.0, "total_liabilities": 21274000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.06318815957133989, "net_margin": -1.3159166666666666, "revenue_growth_yoy": 1.257251420187352, "roa_avg2y": -0.2606295976589385, "roa_period_end": -0.22057488315439822, "roe_avg2y": -0.28592121821161176, "roe_period_end": -0.23451260406858798 } }, { "accn": "0001558370-25-001317", "filed": "2026-02-25", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 795000.0, "cash": 125744000.0, "eps_diluted": -2.6, "free_cash_flow": -108932000.0, "net_income": -127393000.0, "operating_cash_flow": -108137000.0, "operating_income": -131373000.0, "revenue": 26581000.0, "stockholders_equity": 215608000.0, "total_assets": 247928000.0, "total_liabilities": 32320000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.1499016734072947, "revenue_growth_yoy": -0.028365683371714735, "roa_avg2y": -0.4277638707706049, "roa_period_end": -0.5138306282469104, "roe_avg2y": -0.4941265910179606, "roe_period_end": -0.5908546992690438 } }, { "accn": "0001558370-25-001317", "filed": "2025-02-21", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1101000.0, "cash": 123665000.0, "eps_diluted": -2.71, "free_cash_flow": -108966000.0, "net_income": -125551000.0, "operating_cash_flow": -107865000.0, "operating_income": -125845000.0, "revenue": 27357000.0, "stockholders_equity": 300021000.0, "total_assets": 347695000.0, "total_liabilities": 47674000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.15890221017862083, "revenue_growth_yoy": -0.04439709375436635, "roa_avg2y": -0.3735730767685814, "roa_period_end": -0.3610952127583083, "roe_avg2y": -0.4332130835865134, "roe_period_end": -0.41847404015052286 } }, { "accn": "0001558370-24-001850", "filed": "2024-02-27", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 471000.0, "cash": 117358000.0, "eps_diluted": -1.92, "free_cash_flow": -72955000.0, "net_income": -66150000.0, "operating_cash_flow": -72484000.0, "operating_income": -64516000.0, "revenue": 28628000.0, "stockholders_equity": 279606000.0, "total_assets": 324468000.0, "total_liabilities": 44862000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.16044720070384755, "revenue_growth_yoy": 122.93073593073593, "roa_avg2y": -0.275978597578147, "roa_period_end": -0.20387218462221235, "roe_avg2y": -0.36793948327168563, "roe_period_end": -0.23658290594622433 } }, { "accn": "0001558370-23-003906", "filed": "2023-03-15", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 967000.0, "cash": 33006000.0, "free_cash_flow": -42494000.0, "net_income": -77187000.0, "operating_cash_flow": -41527000.0, "operating_income": -80521000.0, "revenue": 231000.0, "stockholders_equity": 79964000.0, "total_assets": 154917000.0, "total_liabilities": 74953000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.9373343004351958, "revenue_growth_yoy": -0.9925303152789006, "roa_avg2y": -0.5243877998158899, "roa_period_end": -0.49824744863378456, "roe_avg2y": -0.8020303513630058, "roe_period_end": -0.9652718723425542 } }, { "accn": "0001558370-22-002385", "filed": "2022-02-28", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 486000.0, "cash": 82233000.0, "free_cash_flow": -50433000.0, "net_income": -38924000.0, "operating_cash_flow": -49947000.0, "operating_income": -42269000.0, "revenue": 30925000.0, "stockholders_equity": 112515000.0, "total_assets": 139472000.0, "total_liabilities": 26957000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.23958583300004443, "net_margin": -1.2586580436540016, "operating_margin": -1.3668229587712206, "revenue_growth_yoy": 0.5413946069879878, "roa_avg2y": -0.2567495366186685, "roa_period_end": -0.2790811058850522, "roe_avg2y": -0.3339009294565231, "roe_period_end": -0.345944985113096 } }, { "accn": "0001558370-21-002715", "filed": "2021-03-10", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 666000.0, "cash": 106029000.0, "free_cash_flow": 3206000.0, "net_income": -36957000.0, "operating_cash_flow": 3872000.0, "operating_income": -37897000.0, "revenue": 20063000.0, "stockholders_equity": 120632000.0, "total_assets": 163734000.0, "total_liabilities": 43102000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.3573015451953047, "roa_avg2y": -0.28679517623504214, "roa_period_end": -0.2257136575176811, "roe_avg2y": -0.355036577692171, "roe_period_end": -0.3063614961204324 } }, { "accn": "0001558370-20-002334", "filed": "2020-03-10", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 347000.0, "cash": 21084000.0, "free_cash_flow": -30319000.0, "net_income": -37177000.0, "operating_cash_flow": -29972000.0, "operating_income": -32666000.0, "stockholders_equity": 87555000.0, "total_assets": 93990000.0, "total_liabilities": 6435000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.07349665924276169, "roa_period_end": -0.3955420789445686, "roe_period_end": -0.424613100336931 } } ], "latest_filing": { "accn": "0001104659-26-019696", "filed": "2026-02-25", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001377121.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001377121.json" }, "ticker": "PTGX" }